Tolerability and Efficacy of Chemotherapy Containing Bedaquiline in Patients with Multiple Drug Resistant Pulmonary Tuberculosis

Tolerability and Efficacy of Chemotherapy Containing Bedaquiline in Patients with Multiple Drug Resistant Pulmonary Tuberculosis

The objective: to evaluate safety and efficacy of bedaquiline in the treatment of patients with multiple drug resistant tuberculosis (MDR-TB).Subjects and Methods. Clinical data of 523 patients above 18 years old registered for MDR TB treatment as per regimen 4 were retrospectively analyzed. HIV-neg...

Full description

Bibliographic Details
Main Authors:	O. V. Filinyuk, D. Yu. Schegertsov, N. N. Kabanets, D. E. Amichba
Format:	Article
Language:	Russian
Published:	New Terra Publishing House 2022-10-01
Series:	Туберкулез и болезни лёгких
Subjects:	туберкулез множественная лекарственная устойчивость бедаквилин эффективность лечения неблагоприятные побочные реакции исход
Online Access:	https://www.tibl-journal.com/jour/article/view/1676

Similar Items

Use of bedaquiline in the chemotherapy regimen for multiple drug resistant tuberculosis in the HIV positive patient
by: N. D. Pirogova, et al.
Published: (2019-11-01)

EXPERIENCE OF USING BEDAQUILINE IN THE TREATMENT OF PULMONARY TUBERCULOSIS PATIENTS WITH MULTIPLE ANDEXTENSIVE DRUG RESISTANCE
by: N. M. Konovаlovа, et al.
Published: (2018-01-01)

Results of treatment with bedaquiline containing regimens of MDR/XDR tuberculosis patients including those with concurrent HIV infection (the experience of Leningrad Region)
by: T. I. Danilova, et al.
Published: (2020-10-01)

Tolerability of individual chemotherapy regimens in children suffering from respiratory tuberculosis and exposed to multiple and extensive drug resistant tuberculosis
by: M. F. Gubkinа, et al.
Published: (2021-04-01)

Experience of using two courses of bedaquiline in the adolescent with extensive drug resistant fibrous cavernous tuberculosis
by: L. V. Pаnovа, et al.
Published: (2019-08-01)

The multivariate analysis of results of bedaquiline use in the therapy of MDR/XDR pulmonary tuberculosis
by: N. V. Stavitskaya, et al.
Published: (2020-08-01)

EXPERIENCE OF TREATMENT OF MULTIPLE DRUG RESISTANT TUBERCULOSIS PATIENTS WITH BEDAQUILINE IN AMUR REGION
by: L. Yu. Tikhonova, et al.
Published: (2018-07-01)

Clinical and economic aspects of enhanced treatment efficacy of multiple drug resistant tuberculosis
by: Yu. M. Markelov, et al.
Published: (2020-10-01)

ADVERSE EVENTS DURING TREATMENT OF PATIENTS SUFFERING FROM MULTIPLE DRUG RESISTANT TUBERCULOSIS
by: D. Yu. Schegertsov, et al.
Published: (2018-04-01)

A CASE OF EFFECTIVE TREATMENT IN A PATIENT WITH MULTIDRUG-RESISTANT PULMONARY TUBERCULOSIS CONCURRENT WITH CHRONIC RENAL FAILURE AFTER KIDNEY TRANSPLANTATION
by: O. G. Komissarova, et al.
Published: (2014-02-01)

RISK FACTORS FOR INEFFECTIVE CHEMOTHERAPY IN PATIENTS WITH MULTIDRUG-RESISTANT TUBERCULOSIS
by: O. V. Filinyuk, et al.
Published: (2014-01-01)

Аnalysis of the tuberculosis situation in the Republic of Tajikistan
by: U. Yu. Sirodzhidinova, et al.
Published: (2015-02-01)

MDR tuberculosis and HIV infection in the North-Western Federal District
by: Z. M. Zagdyn, et al.
Published: (2021-02-01)

Experience of Using Bedaquiline in a Young Child with Drug Resistant Tuberculosis and Concurrent Primary Immunodeficiency
by: T. I. Danilova, et al.
Published: (2021-09-01)

IMPACT OF BEDAQUILINE ON THE EFFICIENCY OF COMPREHENSIVE THERAPY OF RESPIRATORY TUBERCULOSIS
by: M. N. Kondakova, et al.
Published: (2018-07-01)

Eﬃcacy of using bedaquiline in treatment of tuberculosis patients with multiple and extensive drug resistance
by: A. A. Starshinova, et al.
Published: (2022-06-01)

ANALYSIS OF THE PATIENTS REFERRED FOR TREATMENT TO NOVOSIBIRSK TUBERCULOSIS RESEARCH INSTITUTE FROM THE AREAS SUPERVISED BY THIS INSTITUTE. CHANGES IN CHEMOTHERAPY EFFICIENCY AFTER INTRODUCTION OF THE UPDATED TREATMENT REGIMENS AND MICROBIOLOGICAL DIAGNOSTICS
by: E. P. Myshkova, et al.
Published: (2017-09-01)

Drug susceptibility of M. tuberculosis in tuberculosis patients from various population groups in Khanty-Mansiyskiy Autonomous Region
by: Yu. V. Reshetnikova, et al.
Published: (2015-11-01)

EXPERIENCE OF USING BEDAQUILINE AND LINEZOLID IN THE INTEGRAL TREATMENT OF THE PULMONARY TUBERCULOSIS PATIENT WITH EXTENSIVE DRUG RESISTANCE OF M. TUBERCULOSIS
by: E. M. Zhukova, et al.
Published: (2016-10-01)

Hepatotoxic reactions during treatment of newly diagnosed patients with pulmonary multiple drug resistant tuberculosis
by: R. Yu. Аbdullаev, et al.
Published: (2019-08-01)

Social aspects multi-drug resistant tuberculosis
by: O. V. Filinyuk, et al.
Published: (2012-08-01)

Safety of treatment regimens in multiple drug resistant tuberculosis patients compiled as per the new WHO recommendations as of 2019
by: D. A. Ivanova, et al.
Published: (2020-02-01)

CHANGES IN THE PREVALENCE OF DRUG RESISTANT TUBERCULOSIS
by: V. B. Galkin, et al.
Published: (2017-03-01)

Prevalence of Extensively Drug-Resistant Tuberculosis: a Descriptive Study
by: O. A. Pasechnik, et al.
Published: (2018-09-01)

DRUG RESISTANCE OF STRAINS OF M. TUBERCULOSIS, ISOLATED FROM PULMONARY TUBERCULOSIS PATIENTS IN VLADIMIR REGION IN 2013
by: E. S. Dyuzhik, et al.
Published: (2015-10-01)

THE EFFICIENCY OF TREATMENT IN MULTIDRUG-RESISTANT TUBERCULOSIS PATIENTS REGISTERED IN 2010
by: S. A. Sterlikov, et al.
Published: (2014-03-01)

EFFICIENCY OF INPATIENT TREATMENT OF TUBERCULOSIS PATIENTS WITH DRUG-RESISTANT TB
by: I. F. Kopylova, et al.
Published: (2013-02-01)

Predictors of failure in treatment according program DOTS-PLUS in patients suffering from multidrug-resistant tuberculosis
by: I. G. Felker, et al.
Published: (2012-08-01)

EXPERIENCE OF USING THE TB DRUG OF PERCHLOZON IN TUBERCULOSIS PATIENTS WITH MULTIPLE DRUG RESISTANCE IN BURYATIA REPUBLIC
by: S. V. Nikolaeva
Published: (2015-10-01)

Risk factors for multiple drug resistant tuberculosis relapses
by: А. S. Аlliluev, et al.
Published: (2020-12-01)

EFFICIENCY OF CHEMOTHERAPY WITH BEDAQUILINE IN DRUG RESISTANT PULMONARY TUBERCULOSIS PATIENTS
by: A. M. Tikhonov, et al.
Published: (2018-03-01)

Automated plasmapheresis for management of hepatotoxic reactions to chemotherapy in pulmonary tuberculosis patients with multiple drug resistance including those with concurrent viral hepatitis
by: E. V. Vаniev, et al.
Published: (2018-11-01)

Differentiated Approaches to the Choice of Timing of Surgical Treatment for Intrathoracic Lymph Node Tuberculosis in Children during Increasing Incidence of Multiple Drug Resistant Tuberculosis
by: M. F. Gubkina, et al.
Published: (2022-08-01)

CORRELATIONS BETWEEN MEDICAL-ECONOMIC AND EPIDEMIOLOGICAL RATES WITH THE FREQUENCY OF TREATMENT DEFAULTS IN TUBERCULOSIS PATIENTS
by: I. M. Son, et al.
Published: (2016-07-01)

Medications for Short-Course Chemotherapy of Drug Resistant Tuberculosis and Their Effect on the Host
by: G. N. Mozhokina, et al.
Published: (2022-09-01)

Efcacy and safety of combination therapy with bedaquiline in a multimorbid HIV positive patient with multiple drug resistant tuberculosis
by: E. M. Zhukova, et al.
Published: (2022-07-01)

Social and demographic factors contributing to the spread of multiple drug resistant tuberculosis in the Russian Federation: a systematic review
by: I. A. Bykov
Published: (2022-07-01)

Apical pleurectomy as a technique of elimination of continuous exudation after pulmonary resection due to multiple drug resistant tuberculosis
by: S. A. Belov, et al.
Published: (2016-01-01)

A clinical case of successful combined treatment of a patient with fibrous cavernous pulmonary tuberculosis and extensive drug resistance
by: P. N. Golubchikov, et al.
Published: (2020-07-01)

Use of mesenchymal stem cells in therapy of tuberculosis
by: А. N. Remezova, et al.
Published: (2022-05-01)